메뉴 건너뛰기




Volumn 28, Issue 12, 2010, Pages 2494-2496

Issues in the development of new combinations of blood pressure lowering drugs

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; POLYPILL; RAMIPRIL; RENIN ANGIOTENSIN SYSTEM ANTAGONIST; SIMVASTATIN; UNCLASSIFIED DRUG;

EID: 79956329624     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328340d702     Document Type: Article
Times cited : (2)

References (9)
  • 3
    • 0344718782 scopus 로고    scopus 로고
    • 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement of management of hypertension
    • World Health Organization, International Society of Hypertension Writing Group
    • World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement of management of hypertension. Journal of Hypertension 2003; 21:1983-1992.
    • Journal of Hypertension , vol.2003 , Issue.21 , pp. 1983-1992
  • 4
    • 84862888718 scopus 로고    scopus 로고
    • National institute for health and clinical excellence. Hypertension: Management of hypertension in adults in primary care (partial update of NICE clinical guideline 18)
    • June 2006
    • National Institute for Health and Clinical Excellence. Hypertension: management of hypertension in adults in primary care (partial update of NICE clinical guideline 18). Clinical Guideline 34. 2006; June 2006.
    • (2006) Clinical Guideline , vol.34
  • 5
    • 33745685204 scopus 로고    scopus 로고
    • The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy
    • Khan NA, McAlister FA, Rabkin SW, Padwal R, Feldman RD, Campbell NR, et al. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. Canadian Journal of Cardiology 2006; 22:583-593.
    • Canadian Journal of Cardiology , vol.2006 , Issue.22 , pp. 583-593
    • Khan, N.A.1    McAlister, F.A.2    Rabkin, S.W.3    Padwal, R.4    Feldman, R.D.5    Campbell, N.R.6
  • 6
    • 57349138291 scopus 로고    scopus 로고
    • Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
    • for the ACCOMPLISH trial investigators
    • Jamerson K, Weber MA, Bakris GL, et al., for the ACCOMPLISH trial investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. New England Journal of Medicine 2008; 359:2417-2428.
    • (2008) New England Journal of Medicine , vol.359 , pp. 2417-2428
    • Jamerson, K.1    Weber, M.A.2    Bakris, G.L.3
  • 7
    • 42049107348 scopus 로고    scopus 로고
    • The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events
    • The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. New England Journal of Medicine. 2008; 358:1547-1559.
    • (2008) New England Journal of Medicine. , vol.358 , pp. 1547-1559
  • 8
    • 34047197931 scopus 로고    scopus 로고
    • Effect of spironolactone on blood pressure in subjects with resistant hypertension
    • DOI 10.1161/01.HYP.0000259805.18468.8c
    • Chapman N, Dobson J, Wilson S, et al., on behalf of the Anglo-Scandinavian Cardiac Outcomes Trial Investigators. Effect of Spironolactone on Blood Pressure in Subjects with Resistant Hypertension. Hypertension 2007; 49:839-845. (Pubitemid 351664214)
    • (2007) Hypertension , vol.49 , Issue.4 , pp. 839-845
    • Chapman, N.1    Dobson, J.2    Wilson, S.3    Dahlof, B.4    Sever, P.S.5    Wedel, H.6    Poulter, N.R.7
  • 9
    • 64349095030 scopus 로고    scopus 로고
    • Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): A phase II, double-blind, randomized trial
    • The Indian Polycap Study (TIPS)
    • The Indian Polycap Study (TIPS). Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): A phase II, double-blind, randomized trial. Lancet 2009; 373:1341-1351.
    • (2009) Lancet , vol.373 , pp. 1341-1351


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.